COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval

The Food and Drug Administration has granted the first full approval to a COVID-19 vaccine, a milestone in the pandemic. The vaccine, manufactured by Pfizer/BioNTech, was developed based on modified mRNA technology that Katalin Karikó and Drew Weissman of the Perelman School of Medicine invented, a breakthrough that Dean J. Larry Jameson calls “one the world’s most impactful scientific achievements.” 

For more details, visit